With Vuity Approval, AbbVie Continues Stepping Into Eye Care

Presbyopia Drug Carries On Allergan Legacy

AbbVie had no presence in ophthalmic medicine other than a single indication for Humira before the Allergan merger, but now has a growing eye care portfolio, including early FDA approval of Vuity for presbyopia.

Eye in an high tech environment
AbbVie has more ophthalmology plans beyond first eye drop approval for presbyopia

More from New Products

More from Scrip